News
Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...
If your physician prescribes a new branded drug, though, you and your insurance company have few options. Patent-protected ...
Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.
13h
Zacks Investment Research on MSNPfizer (PFE) Outperforms Broader Market: What You Need to KnowPfizer (PFE) closed at $25.32 in the latest trading session, marking a +1.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.48% for the day. Elsewhere, the Dow ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma giant colluded to “deliberately slow down” clinical tests of its COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results